CENTRAL LABORATORIES WHITE PAPERS & ARTICLES

CENTRAL LABORATORIES APPLICATIONS & STUDIES

CENTRAL LABORATORIES PRODUCTS & SERVICES

See our exciting new solution for medical monitors, Revvity Signals Software Signals™ Medical Review which empowers clinical development teams and medical monitors to detect safety signals faster and reduce time to submission by combining innovative medical review workflow with advanced analytics.

At inSeption Group, we don’t just crunch numbers—we transform data into confident action. Your trial’s success hinges on how well data is planned, analyzed, and delivered, and we make sure every finding moves your program forward.

Change how you compete by getting the clinical data services and support you need. Medrio is here to help clinical trial sponsors and CROs build internal expertise and support any clinical trial data management needs.

Zelta’s EDC has been used in more than 4,000 studies from startup to submission, across all phases, including over 500 phase 3c trials and 23 therapeutic areas.

Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.

They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.

Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.

Early Phase Experts

As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.

With a broad range of experience delivering Phase 1 Healthy Volunteer, First in Human, First in Patient and Phase 2 trials, we know just how important it is for your asset to succeed in the early development lifecycle. Our experienced team will help you obtain high-quality data that will appeal to future investors, meet the requirements of international regulatory bodies such as the FDA, EMA, PMDA, and Health Canada, and prepare your product for larger Phase 3 and 4 studies, partnerships, licensing, and sale.

Whatever your clinical trial needs, we can provide a flexible, bespoke solution that will not only meet your regulatory requirements but also position your product for commercial success.

Worldwide Flex provides flexible, scalable solutions and services to enhance our clients’ outsourcing needs. We are a specialized provider of multi-therapeutic functional solutions delivered by our experts.

ICON Commercialization & Outcomes (ICO) optimizes the value of drugs and medical devices through innovative strategies and tactics that reflect evolving evidentiary, regulatory, and reimbursement requirements.